{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T16:21:05Z","timestamp":1793204465073,"version":"4.5.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T00:00:00Z","timestamp":1648080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T00:00:00Z","timestamp":1648080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Pediatric Clinical Research Center Foundation of Sichuan Province, China","award":["No. 2017-46-4"],"award-info":[{"award-number":["No. 2017-46-4"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Pediatr"],"published-print":{"date-parts":[[2022,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The effect of fish oil-containing lipid emulsions on preventing parenteral nutrition-associated cholestasis (PNAC) in very low birth weight (VLBW) infants is not known. Thus, we conducted a meta-analysis to identify any prevention effect.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>PubMed, EMBASE, and CENTRAL were searched up to 26 January 2021 for studies related to the preventive effect of fish oil-containing lipid emulsions and fish oil-free lipid emulsions on cholestasis in VLBW infants. Revman 5.3 was used to synthesize the results. A fixed-effect model was used to summarize the data when the heterogeneity was non-significant (<jats:italic>I<\/jats:italic><jats:sup>2<\/jats:sup>\u2009&lt;\u200950%), and a random-effects model was used when the heterogeneity was significant (<jats:italic>I<\/jats:italic><jats:sup>2<\/jats:sup>\u2009&gt;\u200950%).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Of 728 articles, 11 randomized controlled trials met the inclusion criteria. The meta-analysis indicated that fish oil-containing lipid emulsion reduced the occurrence of PNAC significantly with risk ratio (RR)\u2009=\u20090.53, 95% confidence interval (CI) 0.36\u20130.80, <jats:italic>P<\/jats:italic>\u2009=\u20090.002. The heterogeneity was non-significant with <jats:italic>I<\/jats:italic><jats:sup>2<\/jats:sup>\u2009=\u200923%. Subgroup analysis based on parenteral nutrition duration and median birth weight was performed. The synthesis results for patients with parenteral nutrition duration exceeding 14\u00a0days revealed <jats:italic>I<\/jats:italic><jats:sup>2<\/jats:sup>\u2009=\u200935% (<jats:italic>P<\/jats:italic>\u2009=\u20090.15) and pooled RR\u2009=\u20090.47, 95% CI 0.30\u20130.73, <jats:italic>P<\/jats:italic>\u2009=\u20090.0008; and for patients with duration less than 14\u00a0days revealed <jats:italic>I<\/jats:italic><jats:sup>2<\/jats:sup>\u2009=\u20090% (<jats:italic>P<\/jats:italic>\u2009=\u20090.72) and pooled RR\u2009=\u20091.14, 95% CI 0.39\u20133.35, <jats:italic>P<\/jats:italic>\u2009=\u20090.81. The synthesis for patients with birth weight more than 1000\u00a0g revealed <jats:italic>I<\/jats:italic><jats:sup>2<\/jats:sup>\u2009=\u20090% (<jats:italic>P<\/jats:italic>\u2009=\u20090.41) and pooled RR\u2009=\u20090.55, 95% CI 0.26\u20131.18, <jats:italic>P<\/jats:italic>\u2009=\u20090.12; and for patients with birth weight below 1000\u00a0g revealed <jats:italic>I<\/jats:italic><jats:sup>2<\/jats:sup>\u2009=\u200944% (<jats:italic>P<\/jats:italic>\u2009=\u20090.11) and pooled RR\u2009=\u20090.53, 95% CI 0.33\u20130.85, <jats:italic>P<\/jats:italic>\u2009=\u20090.009.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The fish oil-containing lipid emulsion can reduce the occurrence of PNAC in VLBW infants based on the available original randomized controlled trial studies, especially for patients with parenteral nutrition duration exceeding 14\u00a0days and extremely low birth weight infants. Future studies should be performed before a definitive conclusion can be established.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s12519-022-00536-2","type":"journal-article","created":{"date-parts":[[2022,3,25]],"date-time":"2022-03-25T12:12:40Z","timestamp":1648210360000},"page":"463-471","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Fish oil-containing lipid emulsions prevention on parenteral nutrition-associated cholestasis in very low birth weight infants: a meta-analysis"],"prefix":"10.1007","volume":"18","author":[{"given":"Ting-Ting","family":"Zou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Rong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Min","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,24]]},"reference":[{"key":"536_CR1","first-page":"E1","volume":"107","author":"JA Lemons","year":"2001","unstructured":"Lemons JA, Bauer CR, Oh W, Korones SB, Papile LA, Stoll BJ, et al. Very low birth weight outcomes of the National Institute of Child health and human development neonatal research network, January 1995 through December 1996. NICHD Neonatal Res Netw Pediatr. 2001;107:E1.","journal-title":"NICHD Neonatal Res Netw Pediatr"},{"issue":"147","key":"536_CR2","first-page":"e1","volume":"196","author":"AA Fanaroff","year":"2007","unstructured":"Fanaroff AA, Stoll BJ, Wright LL, Carlo WA, Ehrenkranz RA, Stark AR, et al. Trends in neonatal morbidity and mortality for very low birthweight infants. Am J Obstet Gynecol. 2007;196:e1\u20138.","journal-title":"Am J Obstet Gynecol"},{"key":"536_CR3","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1542\/peds.2011-3028","volume":"129","author":"JD Horbar","year":"2012","unstructured":"Horbar JD, Carpenter JH, Badger GJ, Kenny MJ, Soll RF, Morrow KA, et al. Mortality and neonatal morbidity among infants 501\u20131500 grams from 2000 to 2009. Pediatrics. 2012;129:1019\u201326.","journal-title":"Pediatrics"},{"key":"536_CR4","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.3346\/jkms.2017.32.8.1228","volume":"32","author":"SH Chung","year":"2017","unstructured":"Chung SH, Bae CW. Improvement in the survival rates of very low birth weight infants after the establishment of the Korean Neonatal Network: comparison between the 2000s and 2010s. J Korean Med Sci. 2017;32:1228\u201334.","journal-title":"J Korean Med Sci"},{"key":"536_CR5","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3233\/NPM-200595","volume":"14","author":"MA AlQurashi","year":"2021","unstructured":"AlQurashi MA. Survival rate of very low birth weight infants over a quarter century (1994\u20132019): a single-institution experience. J Neonatal Perinatal Med. 2021;14:253\u201360.","journal-title":"J Neonatal Perinatal Med"},{"key":"536_CR6","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.siny.2016.08.002","volume":"22","author":"P Patel","year":"2017","unstructured":"Patel P, Bhatia J. Total parenteral nutrition for the very low birth weight infant. Semin Fetal Neonatal Med. 2017;22:2\u20137.","journal-title":"Semin Fetal Neonatal Med"},{"key":"536_CR7","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1177\/0148607113496280","volume":"38","author":"G Lauriti","year":"2014","unstructured":"Lauriti G, Zani A, Aufieri R, Cananzi M, Chiesa PL, Eaton S, et al. Incidence, prevention, and treatment of parenteral nutrition-associated cholestasis and intestinal failure-associated liver disease in infants and children: a systematic review. JPEN J Parenter Enteral Nutr. 2014;38:70\u201385.","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"536_CR8","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.dld.2015.11.003","volume":"48","author":"G Orso","year":"2016","unstructured":"Orso G, Mandato C, Veropalumbo C, Cecchi N, Garzi A, Vajro P. Pediatric parenteral nutrition-associated liver disease and cholestasis: novel advances in pathomechanisms-based prevention and treatment. Dig Liver Dis. 2016;48:215\u201322.","journal-title":"Dig Liver Dis"},{"key":"536_CR9","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1097\/MPG.0000000000000586","volume":"60","author":"F Lacaille","year":"2015","unstructured":"Lacaille F, Gupte G, Colomb V, D\u2019Antiga L, Hartman C, Hojsak I, et al. Intestinal failure-associated liver disease: a position paper of the ESPGHAN Working Group of Intestinal Failure and Intestinal Transplantation. J Pediatr Gastroenterol Nutr. 2015;60:272\u201383.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"536_CR10","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1542\/peds.64.3.342","volume":"64","author":"EF Beale","year":"1979","unstructured":"Beale EF, Nelson RM, Bucciarelli RL, Donnelly WH, Eitzman DV. Intrahepatic cholestasis associated with parenteral nutrition in premature infants. Pediatrics. 1979;64:342\u20137.","journal-title":"Pediatrics"},{"key":"536_CR11","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/sj.jp.7211686","volume":"27","author":"RD Christensen","year":"2007","unstructured":"Christensen RD, Henry E, Wiedmeier SE, Burnett J, Lambert DK. Identifying patients, on the first day of life, at high-risk of developing parenteral nutrition-associated liver disease. J Perinatol. 2007;27:284\u201390.","journal-title":"J Perinatol"},{"key":"536_CR12","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/S0899-9007(97)00233-5","volume":"14","author":"PT Clayton","year":"1998","unstructured":"Clayton PT, Whitfield P, Iyer K. The role of phytosterols in the pathogenesis of liver complications of pediatric parenteral nutrition. Nutrition. 1998;14:158\u201364.","journal-title":"Nutrition"},{"key":"536_CR13","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1097\/MCO.0b013e3283385407","volume":"13","author":"B Koletzko","year":"2010","unstructured":"Koletzko B, Goulet O. Fish oil containing intravenous lipid emulsions in parenteral nutrition-associated cholestatic liver disease. Curr Opin Clin Nutr Metab Care. 2010;13:321\u20136.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"536_CR14","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1097\/SLA.0b013e3181b36657","volume":"250","author":"M Puder","year":"2009","unstructured":"Puder M, Valim C, Meisel JA, Le HD, de Meijer VE, Robinson EM, et al. Parenteral fish oil improves outcomes in patients with parenteral nutrition-associated liver injury. Ann Surg. 2009;250:395\u2013402.","journal-title":"Ann Surg"},{"key":"536_CR15","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3945\/an.113.004796","volume":"5","author":"DG Burrin","year":"2014","unstructured":"Burrin DG, Ng K, Stoll B, S\u00e1enz-De-Pipa\u00f3n M. Impact of new-generation lipid emulsions on cellular mechanisms of parenteral nutrition-associated liver disease. Adv Nutr. 2014;5:82\u201391.","journal-title":"Adv Nutr"},{"key":"536_CR16","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1203\/01.PDR.0000153672.43030.75","volume":"57","author":"IP Alwayn","year":"2005","unstructured":"Alwayn IP, Gura K, Nos\u00e9 V, Zausche B, Javid P, Garza J, et al. Omega-3 fatty acid supplementation prevents hepatic steatosis in a murine model of nonalcoholic fatty liver disease. Pediatr Res. 2005;57:445\u201352.","journal-title":"Pediatr Res"},{"key":"536_CR17","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1203\/00006450-199902000-00008","volume":"45","author":"JE Van Aerde","year":"1999","unstructured":"Van Aerde JE, Duerksen DR, Gramlich L, Meddings JB, Chan G, Thomson AB, et al. Intravenous fish oil emulsion attenuates total parenteral nutrition-induced cholestasis in newborn piglets. Pediatr Res. 1999;45:202\u20138.","journal-title":"Pediatr Res"},{"key":"536_CR18","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3945\/jn.114.204974","volume":"145","author":"HW Park","year":"2015","unstructured":"Park HW, Lee NM, Kim JH, Kim KS, Kim SN. Parenteral fish oil-containing lipid emulsions may reverse parenteral nutrition-associated cholestasis in neonates: a systematic review and meta-analysis. J Nutr. 2015;145:277\u201383.","journal-title":"J Nutr"},{"key":"536_CR19","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.earlhumdev.2013.11.002","volume":"90","author":"S Beken","year":"2014","unstructured":"Beken S, Dilli D, Fettah ND, Kabata\u015f EU, Zenciro\u011flu A, Okumu\u015f N. The influence of fish-oil lipid emulsions on retinopathy of prematurity in very low birth weight infants: a randomized controlled trial. Early Hum Dev. 2014;90:27\u201331.","journal-title":"Early Hum Dev"},{"key":"536_CR20","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/j.clnu.2014.01.009","volume":"33","author":"R D'Ascenzo","year":"2014","unstructured":"D\u2019Ascenzo R, Savini S, Biagetti C, Bellagamba MP, Marchionni P, Pompilio A, et al. Higher docosahexaenoic acid, lower arachidonic acid and reduced lipid tolerance with high doses of a lipid emulsion containing 15% fish oil: a randomized clinical trial. Clin Nutr. 2014;33:1002\u20139.","journal-title":"Clin Nutr"},{"key":"536_CR21","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.clnu.2018.06.929","volume":"38","author":"CC Hsiao","year":"2019","unstructured":"Hsiao CC, Lin HC, Chang YJ, Yang SP, Tsao LY, Lee CH, et al. Intravenous fish oil containing lipid emulsion attenuates inflammatory cytokines and the development of bronchopulmonary dysplasia in very premature infants: a double-blind, randomized controlled trial. Clin Nutr. 2019;38:1045\u201352.","journal-title":"Clin Nutr"},{"key":"536_CR22","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.clnesp.2017.04.004","volume":"20","author":"S Najm","year":"2017","unstructured":"Najm S, L\u00f6fqvist C, Hellgren G, Engstr\u00f6m E, Lundgren P, H\u00e5rd AL, et al. Effects of a lipid emulsion containing fish oil on polyunsaturated fatty acid profiles, growth and morbidities in extremely premature infants: a randomized controlled trial. Clin Nutr ESPEN. 2017;20:17\u201323.","journal-title":"Clin Nutr ESPEN"},{"key":"536_CR23","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/ped.13798","volume":"61","author":"H Ozkan","year":"2019","unstructured":"Ozkan H, Koksal N, Dorum BA, Kocael F, Ozarda Y, Bozyigit C, et al. New-generation fish oil and olive oil lipid for prevention of oxidative damage in preterm infants: single center clinical trial at university hospital in Turkey. Pediatr Int. 2019;61:388\u201392.","journal-title":"Pediatr Int"},{"key":"536_CR24","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1177\/0148607113499373","volume":"38","author":"D Pawlik","year":"2014","unstructured":"Pawlik D, Lauterbach R, Walczak M, Hurka\u0142a J, Sherman MP. Fish-oil fat emulsion supplementation reduces the risk of retinopathy in very low birth weight infants: a prospective, randomized study. JPEN J Parenter Enteral Nutr. 2014;38:711\u20136.","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"536_CR25","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jpeds.2017.11.012","volume":"194","author":"A Repa","year":"2018","unstructured":"Repa A, Binder C, Thanhaeuser M, Kreissl A, Pablik E, Huber-Dangl M, et al. A mixed lipid emulsion for prevention of parenteral nutrition associated cholestasis in extremely low birth weight infants: a randomized clinical trial. J Pediatr. 2018;194:87-93.e81.","journal-title":"J Pediatr"},{"key":"536_CR26","doi-asserted-by":"publisher","first-page":"312","DOI":"10.3945\/ajcn.112.056556","volume":"98","author":"S Savini","year":"2013","unstructured":"Savini S, D\u2019Ascenzo R, Biagetti C, Serpentini G, Pompilio A, Bartoli A, et al. The effect of 5 intravenous lipid emulsions on plasma phytosterols in preterm infants receiving parenteral nutrition: a randomized clinical trial. Am J Clin Nutr. 2013;98:312\u20138.","journal-title":"Am J Clin Nutr"},{"key":"536_CR27","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1177\/0884533615602011","volume":"31","author":"M Skouroliakou","year":"2016","unstructured":"Skouroliakou M, Konstantinou D, Agakidis C, Kaliora A, Kalogeropoulos N, Massara P, et al. Parenteral MCT\/\u03c9-3 polyunsaturated fatty acid-enriched intravenous fat emulsion is associated with cytokine and fatty acid profiles consistent with attenuated inflammatory response in preterm neonates: a randomized, double-blind clinical trial. Nutr Clin Pract. 2016;31:235\u201344.","journal-title":"Nutr Clin Pract"},{"key":"536_CR28","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1097\/MPG.0000000000000280","volume":"58","author":"H Vlaardingerbroek","year":"2014","unstructured":"Vlaardingerbroek H, Vermeulen MJ, Carnielli VP, Vaz FM, van den Akker CH, van Goudoever JB. Growth and fatty acid profiles of VLBW infants receiving a multicomponent lipid emulsion from birth. J Pediatr Gastroenterol Nutr. 2014;58:417\u201327.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"536_CR29","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.pedneo.2018.07.012","volume":"60","author":"HY Yildizdas","year":"2019","unstructured":"Yildizdas HY, Poyraz B, Atli G, Sertdemir Y, Mert K, Ozlu F, et al. Effects of two different lipid emulsions on antioxidant status, lipid peroxidation and parenteral nutrition-related cholestasis in premature babies, a randomized-controlled study. Pediatr Neonatol. 2019;60:359\u201367.","journal-title":"Pediatr Neonatol"},{"key":"536_CR30","first-page":"CD009172","volume":"2015","author":"V Kapoor","year":"2015","unstructured":"Kapoor V, Glover R, Malviya MN. Alternative lipid emulsions versus pure soy oil based lipid emulsions for parenterally fed preterm infants. Cochrane Database Syst Rev. 2015;2015:CD009172.","journal-title":"Cochrane Database Syst Rev"},{"key":"536_CR31","first-page":"CD013163","volume":"6","author":"V Kapoor","year":"2019","unstructured":"Kapoor V, Malviya MN, Soll R. Lipid emulsions for parenterally fed preterm infants. Cochrane Database Syst Rev. 2019;6:CD013163.","journal-title":"Cochrane Database Syst Rev"},{"key":"536_CR32","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1016\/j.clnu.2018.10.009","volume":"38","author":"C Biagetti","year":"2019","unstructured":"Biagetti C, Correani A, D\u2019Ascenzo R, Bellagamba MP, Marchionni P, Antognoli L, et al. Does intravenous fish oil affect the growth of extremely low birth weight preterm infants on parenteral nutrition? Clin Nutr. 2019;38:2319\u201324.","journal-title":"Clin Nutr"},{"key":"536_CR33","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1055\/s-0038-1676977","volume":"36","author":"Y Kasirer","year":"2019","unstructured":"Kasirer Y, Bin-Nun A, Raveh A, Schorrs I, Mimouni FB, Hammerman C. SMOFlipid protects preterm neonates against perinatal nutrition-associated cholestasis. Am J Perinatol. 2019;36:1382\u20136.","journal-title":"Am J Perinatol"},{"key":"536_CR34","first-page":"306","volume":"15","author":"D Pawlik","year":"2011","unstructured":"Pawlik D, Lauterbach R, Hurka\u0142a J. The efficacy of fish-oil based fat emulsion administered from the first day of life in very low birth weight newborns. Med Wieku Rozwoj. 2011;15:306\u201311.","journal-title":"Med Wieku Rozwoj"},{"key":"536_CR35","first-page":"552","volume":"29","author":"T Qian","year":"2020","unstructured":"Qian T, Zhang R, Zhu L, Chen C, Cao Y, Wang J. Very low birth weight preterm infant complications where parenteral nutrition is soy or fish oil-based: a retrospective study in Shanghai. Asia Pac J Clin Nutr. 2020;29:552\u20137.","journal-title":"Asia Pac J Clin Nutr"},{"key":"536_CR36","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1038\/s41372-019-0425-7","volume":"39","author":"R Torgalkar","year":"2019","unstructured":"Torgalkar R, Dave S, Shah J, Ostad N, Kotsopoulos K, Unger S, et al. Multi-component lipid emulsion vs soy-based lipid emulsion for very low birth weight preterm neonates: a pre-post comparative study. J Perinatol. 2019;39:1118\u201324.","journal-title":"J Perinatol"},{"key":"536_CR37","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1055\/s-0039-1701026","volume":"38","author":"J Uberos","year":"2021","unstructured":"Uberos J, Jim\u00e9nez-Montilla S, Molina-Oya M, Nieto-G\u00f3mez P, Millan IC. Morbidity outcomes of very low birth weight neonates receiving parenteral nutrition with fish oil enriched lipid emulsion or lipid emulsion with soybean oil: an observational study. Am J Perinatol. 2021;38:952\u20139.","journal-title":"Am J Perinatol"},{"key":"536_CR38","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1080\/14767058.2017.1300644","volume":"31","author":"S Unal","year":"2018","unstructured":"Unal S, Demirel N, Erol S, Isik DU, Kulali F, Iyigun F, et al. Effects of two different lipid emulsions on morbidities and oxidant stress statuses in preterm infants: an observational study. J Matern Fetal Neonatal Med. 2018;31:850\u20136.","journal-title":"J Matern Fetal Neonatal Med"},{"key":"536_CR39","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1002\/jpen.2011","volume":"45","author":"S Franco","year":"2021","unstructured":"Franco S, Goriacko P, Rosen O, Morgan-Joseph T. Incidence of complications associated with parenteral nutrition in preterm infants < 32 weeks with a mixed oil lipid emulsion vs a soybean oil lipid emulsion in a level IV neonatal intensive care unit. JPEN J Parenter Enteral Nutr. 2021;45:1204\u201312.","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"536_CR40","doi-asserted-by":"publisher","first-page":"293","DOI":"10.4103\/1319-3767.141688","volume":"20","author":"TM Alkharfy","year":"2014","unstructured":"Alkharfy TM, Ba-Abbad R, Hadi A, Sobaih BH, AlFaleh KM. Total parenteral nutrition-associated cholestasis and risk factors in preterm infants. Saudi J Gastroenterol. 2014;20:293\u20136.","journal-title":"Saudi J Gastroenterol"},{"key":"536_CR41","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.3390\/nu13082785","volume":"13","author":"M Tessitore","year":"2021","unstructured":"Tessitore M, Sorrentino E, Schiano-Di-Cola G, Colucci A, Vajro P, Mandato C. Malnutrition in pediatric chronic cholestatic disease: an up-to-date overview. Nutrients. 2021;13:2785.","journal-title":"Nutrients"},{"key":"536_CR42","doi-asserted-by":"publisher","first-page":"508","DOI":"10.3390\/nu13020508","volume":"13","author":"G Guthrie","year":"2021","unstructured":"Guthrie G, Burrin D. Impact of parenteral lipid emulsion components on cholestatic liver disease in neonates. Nutrients. 2021;13:508.","journal-title":"Nutrients"}],"container-title":["World Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12519-022-00536-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12519-022-00536-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12519-022-00536-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T13:28:15Z","timestamp":1655472495000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12519-022-00536-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,24]]},"references-count":42,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["536"],"URL":"https:\/\/doi.org\/10.1007\/s12519-022-00536-2","relation":{},"ISSN":["1708-8569","1867-0687"],"issn-type":[{"value":"1708-8569","type":"print"},{"value":"1867-0687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,24]]},"assertion":[{"value":"16 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not needed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"No financial or non-financial benefits have been received or will be received from any party related directly or indirectly to the subject of this article. The authors have no conflict of interest to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}